Pfizer to Pay $11.6 Billion for Migraine Pill Maker Biohaven Pharmaceuticals
Pfizer and Biohaven Pharmaceutical Holding Company announced on Tuesday, that they have struck an agreement under which Pfizer will acquire
Read morePfizer and Biohaven Pharmaceutical Holding Company announced on Tuesday, that they have struck an agreement under which Pfizer will acquire
Read moreFrench pharma giant Sanofi and British pharmatech business Exscientia revealed a ground-breaking research cooperation and licensing agreement to develop up
Read moreThe award-winning Ireland-based medical device company Aerogen and the innovative Chinese vaccine company CanSinoBIO entered into a partnership earlier this
Read moreMerck (MRK) and Ridgeback Biotherapeutics have announced that the Japanese government will acquire approximately 1.6 million courses of molnupiravir (MK-4482,
Read moreSCIEX and Evosep have established a collaboration to co-market solutions designed to enhance the stability of high-throughput proteomics systems for
Read moreTakeda and JCR Pharmaceuticals announced today a geo-based exclusive collaboration and license agreement to commercialize JR-141 (INN: pabinafusp alfa), an
Read moreBoehringer Ingelheim and Twist Bioscience have entered into a research collaboration that covers multiple antibody research programs. Twist Bioscience Corporation,
Read moreSanofi announced that it will purchase U.S. biotech Kadmon to enhance its transplant business for approximately $1.9 billion. Sanofi and
Read moreVertex Pharmaceuticals Incorporated and Arbor Biotechnologies unveiled they have entered into a new cooperation to accelerate the development of novel
Read moreArvinas and Pfizer have announced a global collaboration to develop and commercialize ARV-471, an investigational oral PROTAC® (PROteolysis TArgeting Chimera)
Read more